Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Is vyvanse expensive?Side effects of varenicline?How does advil's safety profile compare to other nsaids?Mounjaro skin irritation?Symptoms of keytruda?
See the DrugPatentWatch profile for keytruda
Keytruda (pembrolizumab) came out in the sense of receiving its first FDA approval in September 2014 for the treatment of advanced melanoma. [1]
After its initial approval in 2014, Keytruda’s use expanded as the FDA approved additional indications over subsequent years (for example, in other cancers and settings), but those later approvals came after the drug’s initial 2014 launch.
Most people asking when Keytruda “came out” mean its first FDA approval, which was September 2014. If you meant a different market (like EU/UK) or the first time it was marketed in a specific country, the dates can differ.
[1] DrugPatentWatch.com – Keytruda (pembrolizumab) history/coverage
Other Questions About Keytruda :